<?xml version="1.0" encoding="UTF-8"?>
<p id="par0245">In a recent 
 <italic>in vitro</italic> study with Vero E6 cells, CQ was effective to inhibit the SARS-CoV-2 infection [
 <xref rid="bib0615" ref-type="bibr">123</xref>,
 <xref rid="bib0620" ref-type="bibr">124</xref>]. In addition 70 % of a patient group treated with HQ combined with Azithromycin had no detectable viral load after 6 days of treatment [
 <xref rid="bib0630" ref-type="bibr">126</xref>]. However, is important to show that this study is an open-label non-randomized clinical trial and the authors didnâ€™t show the inclusion criteria and the triage of patients to ensure patient safety [
 <xref rid="bib0635" ref-type="bibr">127</xref>]. In this case, the use of chloroquine is still controversial and needs more clinical trials.
</p>
